PENUMBRA SYSTEM 3MAX REPERFUSION CATHETER
Report
- Report Number
- 3005168196-2018-00499
- Event Type
- Malfunction
- Date Received
- March 8, 2018
- Date of Event
- February 2, 2018
- Report Date
- February 7, 2018
- Manufacturer
- PENUMBRA, INC.
- Product Code
- NRY
- UDI-DI
- 00814548012490
- PMA / PMN Number
- K160533
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IT
- Reporter Occupation
- PHYSICIAN
Narratives
THIS DEVICE IS AVAILABLE FOR RETURN. A FOLLOW UP MDR WILL BE SUBMITTED UPON COMPLETION OF THE DEVICE INVESTIGATION.
510(K) #: K160449. RESULTS: THE 3MAX WAS FRACTURED APPROXIMATELY 42.0 CM FROM THE HUB. CONCLUSIONS: EVALUATION OF THE RETURNED 3MAX REVEALED IT WAS FRACTURED. THIS DAMAGE MAY HAVE BEEN A RESULT OF FORCEFULLY ADVANCING THE DEVICE AGAINST RESISTANCE WHILE MANIPULATING AT EXTREME ANGLES OUTSIDE THE PATIENT BODY. PENUMBRA CATHETERS ARE VISUALLY INSPECTED DURING IN-PROCESS INSPECTION AND DURING QUALITY INSPECTION AFTER MANUFACTURING. THE MANUFACTURING RECORDS FOR THIS LOT WERE REVIEWED AND DID NOT REVEAL ANY OUTSTANDING DISCREPANCIES, DESIGN, OR QUALITY CONCERNS.
THE PATIENT WAS UNDERGOING A THROMBECTOMY PROCEDURE IN THE M1 OF THE MIDDLE CEREBRAL ARTERY (MCA) USING A PENUMBRA SYSTEM 3MAX REPERFUSION CATHETER (3MAXC). DURING THE PROCEDURE, THE PHYSICIAN ATTEMPTED TO ADVANCE THE 3MAXC THROUGH A PENUMBRA SYSTEM ACE 68 REPERFUSION CATHETER (ACE68), HOWEVER THE PROXIMAL END OF THE 3MAXC STILL OUTSIDE OF THE PATIENT BROKE IN HALF, DESPITE HAVING USED A GUIDEWIRE TO ADVANCE THE 3MAXC. THE 3MAXC WAS THEREFORE RETRACTED AND REMOVED, AND THE PROCEDURE WAS COMPLETED USING A NEW 3MAXC, THE SAME ACE68 AND GUIDEWIRE. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 167524 | PENUMBRA SYSTEM 3MAX REPERFUSION CATHETER | NRY | NRY | PENUMBRA, INC. | F79987 | 00814548012490 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 88 YR |